Inpatient insulin therapy

Current Opinion in Endocrinology, Diabetes and Obesity

Volumn 15, Issue 2, 2008, Pages 159-166

  Braithwaite, Susan Shapiro ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Basal prandial correction therapy; Diabetes patient self management; Hypoglycemia; Insulin analogs; Intravenous insulin infusion

Indexed keywords

INSULIN; ANTIDIABETIC AGENT;

ALGORITHM; DIABETES MELLITUS; ENTERIC FEEDING; GLYCEMIC CONTROL; HOSPITAL PATIENT; HUMAN; HYPOGLYCEMIA; INSULIN TREATMENT; INTENSIVE CARE; OBSERVATIONAL STUDY; PREDICTOR VARIABLE; REVIEW; SELF CARE; THORAX SURGERY; BELGIUM; GLUCOSE BLOOD LEVEL; INSULIN INFUSION; INTENSIVE CARE UNIT; METABOLISM; RANDOMIZED CONTROLLED TRIAL;

ALGORITHMS; BELGIUM; BLOOD GLUCOSE; ENTERAL NUTRITION; HUMANS; HYPOGLYCEMIC AGENTS; INPATIENTS; INSULIN; INSULIN INFUSION SYSTEMS; INTENSIVE CARE UNITS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 42449127112     PISSN: 1752296X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MED.0b013e3282f827e7     Document Type: Review

References (106)

1. Van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in critically ill patients. N Engl J Med 2001; 345:1359-1367.
2. Van den Berghe G, Wilmer A, Hermans G, et al. Intensive insulin therapy in the medical ICU. N Engl J Med 2006; 354:449-461.
3. Van den Berghe G, Wilmer A, Milants I, et al. Intensive insulin therapy in mixed medical/surgical intensive care units: benefit versus harm. Diabetes 2006; 55:3151-3159.
4. Devos P, Preiser JC. Current controversies around tight glucose control in critically ill patients. Curr Opin Clin Nutr Metab Care 2007; 10:206-209.
5. Brunkhorst FM, Engel C, Bloos F, et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 2008; 358:125-139.
6. McMullin J, Brozek J, McDonald E, et al. Lowering of glucose in critical care: a randomized pilot trial. J Crit Care 2007; 22:112-118; discussion 8-9.
7. Braithwaite SS. Defining the benefits of euglycemia in the hospitalized patient. J Hosp Med 2007; 2 (S1):5-12.
8. Furnary AP, Wu Y. Eliminating the diabetic disadvantage: the Portland Diabetic Project. Semin Thorac Cardiovasc Surg 2006; 18:302-308.
9. Ellger B, Debaveye Y, Vanhorebeek I, et al. Survival benefits of intensive insulin therapy in critical illness: impact of maintaining normoglycemia versus glycemia-independent actions of insulin. Diabetes 2006; 55:1096-1105.
10. Monge M, Ledeme N, Mazouz H, et al. Insulin maintains plasma antioxidant capacity at an early phase of kidney transplantation. Nephrol Dial Transplant 2007; 22:1979-1985.
11. Ligtenberg JJ, Meijering S, Stienstra Y, et al. Mean glucose level is not an independent risk factor for mortality in mixed ICU patients. Intensive Care Med 2006; 32:435-438.
12. Nasraway SA Jr. Hyperglycemia during critical illness. JPEN J Parenter Enteral Nutr 2006; 30:254-258.
13. Pittas AG, Siegel RD, Lau J. Insulin therapy and in-hospital mortality in critically ill patients: systematic review and meta-analysis of randomized controlled trials. JPEN J Parenter Enteral Nutr 2006; 30:164-172.
14. Thomas G, Rojas MC, Epstein SK, et al. Insulin therapy and acute kidney injury in critically ill patients a systematic review. Nephrol Dial Transplant 2007; 22:2849-2855.
15. Vanhorebeek I, Langouche L, Van den Berghe G. Tight blood glucose control with insulin in the ICU: facts and controversies. Chest 2007; 132:268-278.
16. Wintergerst KA, Buckingham B, Gandrud L, et al. Association of hypoglycemia, hyperglycemia, and glucose variability with morbidity and death in the pediatric intensive care unit. Pediatrics 2006; 118:173-179.
17. Lacherade JC, Jabre P, Bastuji-Garin S, et al. Failure to achieve glycemic control despite intensive insulin therapy in a medical ICU: incidence and influence on ICU mortality. Intensive Care Med 2007; 33:814-821.
18. Brown JR, Edwards FH, O'Connor GT, et al. The diabetic disadvantage. Historical outcomes measures in diabetic patients undergoing cardiac surgery: the preintravenous insulin era. Semin Thorac Cardiovasc Surg 2006; 18:281-288.
19. Furnary AP, Wu Y. Clinical effects of hyperglycemia in the cardiac surgery population: the Portland diabetic project. Endocr Pract 2006; 12 (Suppl 3):22-26.
20. Gandhi GY, Nuttall GA, Abel MD, et al. Intraoperative hyperglycemia and perioperative outcomes in cardiac surgery patients. Mayo Clin Proc 2005; 80:862-866.
21. Gandhi GY, Nuttall GA, Abel MD, et al. Intensive intraoperative insulin therapy versus conventional glucose management during cardiac surgery: a randomized trial. Ann Intern Med 2007; 146:233-243. This provocative paper will require confirmation at other sites and in other patient populations in order to generalize the findings of the risk-benefit analysis of strict intraoperative glycemic control.
22. Hirsch IB. Inpatient diabetes: review of data from the cardiac care unit. Endocrine Practice 2006; 12 (Suppl 3):27-34.
23. Quinn DW, Pagano D, Bonser RS, et al. Improved myocardial protection during coronary artery surgery with glucose-insulin-potassium: A randomized controlled trial. J Thorac Cardiovasc Surg 2006; 131:34-42.
24. Schmeltz LR, DeSantis AJ, Thiyagarajan V, et al. Reduction of surgical mortality and morbidity in diabetic patients undergoing cardiac surgery with a combined intravenous and subcutaneous insulin glucose management strategy. Diabetes Care 2007; 30:823-828. The authors showed no excess of hyperglycemia-related morbidity or mortality after heart surgery during use of a sequentially applied regimen consisting of induction of euglycemia by the use of intravenous insulin infusion, followed by maintenance of euglycemia through early transition to basal-prandial-correction subcutaneous insulin therapy. The study is of practical importance because maintenance of intravenous insulin infusion after heart surgery when patients are otherwise ready for transfer out of the ICU is beyond the reach of many hospitals.
25. Ingels C, Debaveye Y, Milants I, et al. Strict blood glucose control with insulin during intensive care after cardiac surgery: impact on 4-years survival, dependency on medical care, and quality-of-life. Eur Heart J 2006; 27:2716-2724.
26. Dronge AS, Perkal MF, Kancir S, et al. Long-term glycemic control and postoperative infectious complications. Arch Surg 2006; 141:375-380.
27. Noordzij PG, Boersma E, Schreiner F, et al. Increased preoperative glucose levels are associated with perioperative mortality in patients undergoing noncardiac, nonvascular surgery. Eur J Endocrinol 2007; 156:137-142.
28. Ainla T, Baburin A, Teesalu R, Rahu M. The association between hyperglycaemia on admission and 180-day mortality in acute myocardial infarction patients with and without diabetes. Diabet Med 2005; 22:1321-1325.
29. Cheung NW, Wong VW, McLean M. The Hyperglycemia: Intensive Insulin Infusion In Infarction (HI-5) Study: A randomized controlled trial of insulin infusion therapy for myocardial infarction. Diabetes Care 2006; 29:765-770.
30. Goyal A, Mahaffey KW, Garg J, et al. Prognostic significance of the change in glucose level in the first 24 h after acute myocardial infarction: results from the CARDINAL study. Eur Heart J 2006; 27:1289-1297.
31. Kosiborod M, Rathore SS, Inzucchi SE, et al. Admission glucose and mortality in elderly patients hospitalized with acute myocardial infarction: implications for patients with and without recognized diabetes. Circulation 2005; 111:3078-3086.
32. van der Horst IC, Nijsten MW, Vogelzang M, Zijlstra F. Persistent hyperglycemia is an independent predictor of outcome in acute myocardial infarction. Cardiovasc Diabetol 2007; 6:2.
33. Ahmad R, Cherry RA, Lendel I, et al. Increased hospital morbidity among trauma patients with diabetes mellitus compared with age- and injury severity score-matched control subjects. Arch Surg 2007; 142:613-618.
34. Gale SC, Sicoutris C, Reilly PM, et al. Poor glycemic control is associated with increased mortality in critically ill trauma patients. Am Surg 2007; 73:454-460.
35. Reed CC, Stewart RM, Sherman M, et al. Intensive insulin protocol improves glucose control and is associated with a reduction in intensive care unit mortality. J Am Coll Surg 2007; 204:1048-1054; discussion 54-5.
36. Shin S, Britt RC, Reed SF, et al. Early glucose normalization does not improve outcome in the critically ill trauma population. Am Surg 2007; 73:769-772; discussion 72.
37. Vogelzang M, Nijboer JM, van der Horst IC, et al. Hyperglycemia has a stronger relation with outcome in trauma patients than in other critically ill patients. J Trauma 2006; 60:873-877; discussion 8-9.
38. Sung J, Bochicchio GV, Joshi M, et al. Admission hyperglycemia is predictive of outcome in critically ill trauma patients. J Trauma 2005; 59:80-83.
39. Barsheshet A, Garty M, Grossman E, et al. Admission blood glucose level and mortality among hospitalized nondiabetic patients with heart failure. Arch Intern Med 2006; 166:1613-1619.
40. Eshaghian S, Horwich TB, Fonarow GC. An unexpected inverse relationship between HbA1c levels and mortality in patients with diabetes and advanced systolic heart failure. Am Heart J 2006; 151:91.
41. Kornum JB, Thomsen RW, Riis A, et al. Type 2 diabetes and pneumonia outcomes: A population-based cohort study. Diabetes Care 2007; 30:2251-2257.
42. McAlister FA, Majumdar SR, Blitz S, et al. The relation between hyperglycemia and outcomes in 2,471 patients admitted to the hospital with community-acquired pneumonia. Diabetes Care 2005; 28:810-815.
43. Baker EH, Janaway CH, Philips BJ, et al. Hyperglycaemia is associated with poor outcomes in patients admitted to hospital with acute exacerbations of chronic obstructive pulmonary disease. Thorax 2006; 61:284-289.
44. Finney SJ, Evans TW. Tight glycaemic control in acute exacerbations of COPD. Thorax 2006; 61:275-279.
45. Burroughs V, Weinberger J. Diabetes and stroke. Part two: treating diabetes and stress hyperglycemia in hospitalized stroke patients. Curr Cardiol Rep 2006; 8:29-32.
46. Frontera JA, Fernandez A, Claassen J, et al. Hyperglycemia after SAH: predictors, associated complications, and impact on outcome. Stroke 2006; 37:199-203.
47. Garg R, Chaudhuri A, Munschauer F, Dandona P. Hyperglycemia, insulin, and acute ischemic stroke: a mechanistic justification for a trial of insulin infusion therapy. Stroke 2006; 37:267-273.
48. Gentile NT, Seftchick MW, Huynh T, et al. Decreased mortality by normalizing blood glucose after acute ischemic stroke. Acad Emerg Med 2006; 13:174-180.
49. Dungan K, Chapman J, Braithwaite SS, Buse J. Glucose measurement: confounding issues in setting targets for inpatient management. Diabetes Care 2007; 30:403-409.
50. ACE/ADA Task Force on Inpatient Diabetes. American College of Endocrinology and American Diabetes Association Consensus Statement on Inpatient Diabetes and Glycemic Control. Endocrine Practice 2006; 12 (Suppl 3):3-13.
51. American Diabetes Association. Standards of medical care in diabetes: 2007. Diabetes Care 2008; 30 (Suppl 1):S12-S54.
52. Goldberg PA, Bozzo JE, Thomas PG, et al. "Glucometrics": assessing the quality of inpatient glucose management. Diabetes Technol Ther 2006; 8:560-569. A method of analysis of hospital performance is proposed for assessment hyperglycemia and hypoglycemia.
53. Wexler DJ, Meigs JB, Cagliero E, et al. Prevalence of hyper- and hypoglycemia among inpatients with diabetes: a national survey of 44 U.S. hospitals. Diabetes Care 2007; 30:367-369. Overall glycemic management was suboptimal in 44 US hospitals.
54. Krinsley JS, Jones RL. Cost analysis of intensive glycemic control in critically ill adult patients. Chest 2006; 129:644-650.
55. Newton CA, Young S. Financial implications of glycemic control: results of an inpatient diabetes management program. Endocr Pract 2006; 12 (Suppl 3): 43-48. Cost-effectiveness of a diabetes management program is discussed.
56. Zijlstra JG, Corstjens AM, Tulleken JE, et al. Cost analysis of intensive glycemic control in critically ill adult patients. Chest 2006; 130:1953-1954.
57. Bhatia A, Cadman B, Mackenzie I. Hypoglycemia and cardiac arrest in a critically ill patient on strict glycemic control. Anesth Analg 2006; 102:549-551.
58. Krinsley JS, Grover A. Severe hypoglycemia in critically ill patients: risk factors and outcomes. Crit Care Med 2007; 35:2262-2267. The serious concomitants of hypoglycemia and the associated increase of mortality among critically ill patients are confirmed.
59. Vriesendorp TM, van Santen S, DeVries JH, et al. Predisposing factors for hypoglycemia in the intensive care unit. Crit Care Med 2006; 34:96-101.
60. Varghese P, Gleason V, Sorokin R, et al. Hypoglycemia in hospitalized patients treated with antihyperglycemic agents. J Hosp Med 2007; 2:234-240.
61. Barth M, Oyen L, Warfield K, et al. Comparison of a nurse initiated insulin infusion protocol for intensive insulin therapy between adult surgical trauma, medical and coronary care intensive care patients. BMC Emergency Medicine 2007; 7:14.
62. Boord JB, Sharifi M, Greevy RA, et al. Computer-based insulin infusion protocol improves glycemia control over manual protocol. J Am Med Inform Assoc 2007; 14:278-287. Superiority of a computerized multiplier algorithm over a manual algorithm for intravenous insulin infusion is demonstrated.
63. Boulkina LS, Braithwaite SS. Practical aspects of intensive insulinization in the intensive care unit. Curr Opin Clin Nutr Metab Care 2007; 10:197-205.
64. Braithwaite SS, Edkins R, Macgregor KL, et al. Performance of a dose-defining insulin infusion protocol among trauma service intensive care unit admissions. Diabetes Technol Ther 2006; 8:476-488.
65. Braithwaite SS, Clement S. Algorithms for intravenous insulin delivery. Curr Diabetes Rev (in press).
66. Button E, Keaton P. Glycemic control after coronary bypass graft: using intravenous insulin regulated by a computerized system. Crit Care Nurs Clin North Am 2006; 18:257-265; xi.
67. Clayton SB, Mazur JE, Condren S, et al. Evaluation of an intensive insulin protocol for septic patients in a medical intensive care unit. Crit Care Med 2006; 34:2974-2978.
68. Fabietti PG, Canonico V, Orsini-Federici M, et al. Clinical validation of a new control-oriented model of insulin and glucose dynamics in subjects with type 1 diabetes. Diabetes Technol Ther 2007; 9:327-338.
69. Goldberg PA, Roussel MG, Inzucchi SE. Clinical results of an updated insulin infusion protocol in critically ill patients. Diabetes Spectrum 2005; 18:188-191.
70. Hermayer KL, Neal DE, Hushion TV, et al. Outcomes of a cardiothoracic intensive care web-based online intravenous insulin infusion calculator study at a medical university hospital. Diabetes Technol Ther 2007; 9:523-534.
71. Hovorka R, Kremen J, Blaha J, et al. Blood glucose control by a model predictive control algorithm with variable sampling rate versus a routine glucose management protocol in cardiac surgery patients: a randomized controlled trial. J Clin Endocrinol Metab 2007; 92:2960-2964.
72. Juneja R, Roudebush C, Kumar N, et al. Utilization of a computerized intravenous insulin infusion program to control blood glucose in the intensive care unit. Diabetes Technol Ther 2007; 9:232-240. Computerization assisted in the implementation of a multiplier algorithm. Improvement of glycemic control during intravenous insulin infusion was demonstrated at two hospitals.
73. Lonergan T, Compte AL, Willacy M, et al. A pilot study of the SPRINT protocol for tight glycemic control in critically Ill patients. Diabetes Technol Ther 2006; 8:449-462.
74. Lonergan T, Le Compte A, Willacy M, et al. A simple insulin-nutrition protocol for tight glycemic control in critical illness: development and protocol comparison. Diabetes Technol Ther 2006; 8:191-206.
75. Malesker MA, Foral PA, McPhillips AC, et al. An efficiency evaluation of protocols for tight glycemic control in intensive care units. Am J Crit Care 2007; 16:589-598.
76. Meynaar IA, Dawson L, Tangkau PL, et al. Introduction and evaluation of a computerised insulin protocol. Intensive Care Med 2007; 33:591-596.
77. Oeyen SG, Hoste EA, Roosens CD, et al. Adherence to and efficacy and safety of an insulin protocol in the critically ill: a prospective observational study. Am J Crit Care 2007; 16:599-608.
78. Osburne RC, Cook CB, Stockton L, et al. Improving hyperglycemia management in the intensive care unit: preliminary report of a nurse-driven quality improvement project using a redesigned insulin infusion algorithm. The Diabetes Educator 2006; 32:394-403.
79. Plank J, Blaha J, Cordingley J, et al. Multicentric, randomized, controlled trial to evaluate blood glucose control by the model predictive control algorithm versus routine glucose management protocols in intensive care unit patients. Diabetes Care 2006; 29:271-276.
80. Quinn JA, Snyder SL, Berghoff JL, et al. A practical approach to hyperglycemia management in the intensive care unit: evaluation of an intensive insulin infusion protocol. Pharmacotherapy 2006; 26:1410-1420.
81. Rea RS, Donihi AC, Bobeck M, et al. Implementing an intravenous insulin infusion protocol in the intensive care unit. Am J Health Syst Pharm 2007; 64:385-395.
82. Shulman R, Finney S, O'Sullivan C, et al. Tight glycaemic control: a prospective observational study of a computerised decision-supported intensive insulin therapy protocol. Critical Care 2007; 11:R75.
83. Smith AB, Udekwu PO, Biswas S, et al. Implementation of a nurse-driven intensive insulin infusion protocol in a surgical intensive care unit. Am J Health Syst Pharm 2007; 64:1529-1540.
84. Taylor BE, Schallom ME, Sona CS, et al. Efficacy and safety of an insulin infusion protocol in a surgical ICU. J Am Coll Surg 2006; 202:1-9.
85. Wilson M, Weinreb J, Soo Hoo GW. Intensive insulin therapy in critical care: a review of a dozen protocols. Diabetes Care 2007; 30:1005-1011.
86. Wintergerst KA, Deiss D, Buckingham B, et al. Glucose control in pediatric intensive care unit patients using an insulin and glucose algorithm. Diabetes Technol Ther 2007; 9:211-222.
87. Wong XW, Singh-Levett I, Hollingsworth LJ, et al. A novel, model-based insulin and nutrition delivery controller for glycemic regulation in critically ill patients. Diabetes Technol Ther 2006; 8:174-190.
88. Dortch MJ, Mowery NT, Ozdas A, et al. A computerized insulin infusion titration protocol improves glucose control with less hypoglycemia compared to a manual titration protocol in a trauma intensive care unit. JPEN J Parenter Enteral Nutr 2008; 32:18-27.
89. Bode BW, Braithwaite SS, Steed RD, Davidson PC. Intravenous insulin infusion therapy: indications, methods, and transition to subcutaneous insulin therapy. Endocr Pract 2004; 10 (Suppl 2):71-80.
90. Baldwin D, Villanueva G, McNutt R, Bhatnagar S. Eliminating inpatient sliding-scale insulin: a reeducation project with medical house staff. Diabetes Care 2005; 28:1008-1011.
91. Boullu-Sanchis S, Ortega F, Chabrier G, et al. Efficacy of short term continuous subcutaneous insulin lispro versus continuous intravenous regular insulin in poorly controlled, hospitalized, type 2 diabetic patients. Diabetes Metab 2006; 32:350-357.
92. Braithwaite SS. The transition from insulin infusions to long-term diabetes therapy: the argument for insulin analogs. Semin Thorac Cardiovasc Surg 2006; 18:366-378. The discussion of transitioning from intravenous insulin to subcutaneous management, outlining a plan for basal-prandial-correction therapy using insulin analogs, emphasizes the common error of omission of adequate prandial coverage for patients who are eating, and the paper also discusses a plan for insulin coverage for patients who are not eating.
93. Braithwaite SS, Mehrotra HP, Robertson B, et al. Managing hyperglycemia in hospitalized patients. Clinical Cornerstones 2007; 8:44-57.
94. DeSantis AJ, Schmeltz LR, Schmidt K, et al. Inpatient management of hyperglycemia: the Northwestern experience. Endocr Pract 2006; 12:491-505. A program of basal-prandial-correction therapy is outlined together with description of performance.
95. Donaldson S, Villanuueva G, Rondinelli L, Baldwin D. Rush University guidelines and protocols for the management of hyperglycemia in hospitalized patients: elimination of the sliding scale and improvement of glycemic control throughout the hospital. Diabetes Educ 2006; 32:954-962.
96. Golightly LK, Jones MA, Hamamura DH, et al. Management of diabetes mellitus in hospitalized patients: efficiency and effectiveness of sliding-scale insulin therapy. Pharmacotherapy 2006; 26:1421-1432.
97. Grainger A, Eiden K, Kemper J, Reeds D. A pilot study to evaluate the effectiveness of glargine and multiple injections of lispro in patients with type 2 diabetes receiving tube feedings in a cardiovascular intensive care unit. Nutr Clin Pract 2007; 22:545-552.
98. Holman RR, Thorne KI, Farmer AJ, et al. Addition of biphasic, prandial, or basal insulin to oral therapy in type 2 diabetes. N Engl J Med 2007; 357:1716-1730.
99. Thompson CL, Dunn KC, Menon MC, et al. Hyperglycemia in the Hospital. Diabetes Spectr 2005; 18:20-27.
100. Umpierrez GE, Smiley D, Zisman A, et al. Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes (RABBIT 2 trial). Diabetes Care 2007; 30:2181-2186. The study was the first randomized trial to demonstrate inferiority of sliding scale insulin regimens in comparison to basal-prandial-correction therapy. A treatment regimen utilizing scheduled insulin is outlined for patients who are eating or not eating.
101. Yeldandi RR, Lurie A, Baldwin D. Comparison of once-daily glargine insulin with twice-daily NPH/regular insulin for control of hyperglycemia in inpatients after cardiovascular surgery. Diabetes Technol Ther 2006; 8:609-616.
102. Hirsch IB. Insulin analogues. N Engl J Med 2005; 352:174-183.
103. Trence DL, Kelly JL, Hirsch IB. The rationale and management of hyperglycemia for in-patients with cardiovascular disease: time for change. J Clin Endocrinol Metab 2003; 88:2430-2437.
104. Schoeffler JM, Rice DAK, Gresham DG. 70/30 Insulin algorithm versus sliding scale insulin. Ann Pharmacother 2005; 39:1606-1609.
105. White WA Jr, Montalvo H, Monday JM. Continuous subcutaneous insulin infusion during general anesthesia: a case report. AANA J 2004; 72:353-357.
106. Cook CB, Boyle ME, Cisar NS, et al. Use of continuous subcutaneous insulin infusion (insulin pump) therapy in the hospital setting: proposed guidelines and outcome measures. Diabetes Educ 2005; 31:849-857.